Peptide Synthesis Market Poised to Hit $2.26 Billion by 2033 | GLP-1 Demand, Biopharma Expansion & Advanced Manufacturing Drive 11.4% CAGR

Market Size and Growth 2026

The Global Peptide Synthesis Market reached US$ 780.00 million in 2023, with a rise to US$ 860.99 million in 2024, and is expected to reach US$ 2,268.16 million by 2033, growing at a CAGR of 11.4% during the forecast period 2026-2033.

DataM Intelligence has released a new research report titled Peptide Synthesis Market Size 2026 The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global Peptide Synthesis market.

Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/peptide-synthesis-market?sb

Key Developments 2025-2026:

United States: Recent Industry Developments

✅ In March 2026, Thermo Fisher Scientific expanded its peptide synthesis capabilities by upgrading automated solid-phase synthesis platforms and scaling production capacity. The initiative focuses on supporting growing demand for therapeutic peptides and personalized medicine. It strengthens the company's position in advanced biopharmaceutical manufacturing.

✅ In February 2026, CordenPharma announced a major investment in its U.S. facilities to enhance large-scale peptide manufacturing and purification technologies. The expansion targets increasing demand for GLP-1 and other peptide-based drugs. It boosts capacity for commercial-scale peptide production.

✅ In January 2026, Lonza Group upgraded its peptide synthesis infrastructure with advanced continuous manufacturing technologies and high-efficiency purification systems. The development focuses on improving scalability and reducing production timelines. It reinforces Lonza's leadership in contract development and manufacturing.

✅ In January 2026, Bachem invested in expanding its peptide production operations, including new synthesis lines and process optimization technologies. The initiative supports rising demand for complex and long-chain peptides. It enhances supply capabilities for pharmaceutical clients.

Ready to scale in the Peptide Synthesis Market? Connect with the right partners and unlock new growth opportunities today:- https://www.datamintelligence.com/partner-identification-enquiry/peptide-synthesis-market?sb

Japan: Recent Industry Developments

✅ In March 2026, PeptiDream Inc. advanced its peptide discovery and synthesis platform with new automated technologies for high-throughput peptide generation. The innovation accelerates drug discovery pipelines and improves efficiency. It strengthens Japan's position in peptide-based therapeutics.

✅ In February 2026, Takeda Pharmaceutical Company expanded its peptide R&D and manufacturing capabilities to support next-generation peptide drug development. The initiative focuses on oncology and metabolic disorders. It enhances Takeda's biologics and peptide innovation pipeline.

✅ In January 2026, Ajinomoto Co., Inc. invested in advanced peptide synthesis technologies, including green chemistry approaches and scalable production systems. The development aims to improve efficiency and sustainability in peptide manufacturing. It supports global demand for high-quality peptide ingredients.

✅ In January 2026, Kyowa Kirin strengthened its peptide manufacturing processes with upgraded purification and formulation technologies. The initiative focuses on improving yield and stability of peptide-based drugs. It enhances Japan's capabilities in biopharmaceutical production.

List of Key Players 2026:

=> Bachem, Thermo Fisher Scientific, Merck, GenScript, PolyPeptide Group, Almac Group, Kaneka Eurogentec, Biosynth, BCNPeptides, and CPC Scientific, among others.

Request Strategic Market Customization: https://datamintelligence.com/customize/peptide-synthesis-market?sb

Growth Forecast Projection 2026:

The Global Peptide Synthesis Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

How Our Market Research Process Works:

The global Peptide Synthesis Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the Peptide Synthesis ecosystem.

Recent Mergers & Acquisitions (M & A) 2025-2026:

✅ In April 2026, Bachem announced a strategic partnership and asset acquisition to scale large-scale peptide API production, supporting the rising demand for GLP-1 and next-generation peptide drugs.

✅ In March 2026, Lonza expanded its peptide manufacturing network by acquiring additional synthesis assets, enhancing its capacity for complex and high-potency peptide therapeutics.

✅ In February 2026, WuXi AppTec expanded its peptide and oligonucleotide business via strategic investments and acquisitions, aiming to build an integrated platform for next-gen therapeutics.

✅ In February 2026, CordenPharma acquired peptide production capabilities to expand its CDMO services, addressing growing demand for clinical and commercial-scale peptide manufacturing.

Unlock Full 360° Strategic Report: https://www.datamintelligence.com/buy-now-page?report=peptide-synthesis-market?sb

Major Focused Key Segmentations 2026:

➥ By Technique: Solid Phase Synthesis, Solution Phase Synthesis, Hybrid Approach

➥ By Product Type: Equipment, Reagents & Consumables, Services

➥ By Application: Therapeutic, Diagnostics, Research

➥ By End-User: Pharmaceutical & Biotechnology Companies, CDMOs & CROs, Academic & Research Institutes, Others

➥ By Region: North America, Europe, Asia-Pacific, South America, Middle East & Africa - Share, Size, Outlook, and Opportunity Analysis

Regional Growth Analysis for Market:

⇥ North America: Leads the Peptide Synthesis market with strong R&D investments, advanced material innovation, and growing adoption across electronics, energy storage, and aerospace sectors.

⇥ Asia-Pacific (including Japan): Dominates global demand, driven by large-scale production, expanding applications in electronics, batteries, and industrial manufacturing across China, Japan, and India.

⇥ Europe: Significant growth supported by government-funded research initiatives, sustainability focus, and increasing use in automotive and renewable energy applications.

⇥ Middle East & Africa: Emerging market fueled by rising interest in advanced materials, infrastructure development, and early-stage adoption in energy and construction sectors.

We Provide Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

FAQ

Q1: What is the current size of the Peptide Synthesis Market?

A: The Peptide Synthesis Market was valued at US$ 860.99 million in 2024 and is forecasted to hit US$ 2,268.16 million by 2033

Q2: How rapidly will the Market expanding?

A: The Peptide Synthesis market is projected to grow at a CAGR of 11.4% between 2026 and 2033.

Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.